• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Exploring the food-gut axis in immunotherapy response of cancer patients

    2020-10-29 02:03:34EddaRussoGiuliaNanniniMonicaDinuGiudittaPagliaiFrancescoSofiAmedeoAmedei
    World Journal of Gastroenterology 2020年33期

    Edda Russo, Giulia Nannini, Monica Dinu, Giuditta Pagliai, Francesco Sofi, Amedeo Amedei

    Abstract Nowadays, immunotherapy is widely used to treat different cancer types as it boosts the body's natural defenses against the malignancy, with lower risk of adverse events compared to the traditional treatments. The immune system is able to control cancer growth but, unfortunately, many cancers take advantage of immune checkpoints pathways for the immune evasion. An intricate network of factors including tumor, host and environmental variables influence the individual response to immune checkpoints’ inhibitors. Between them, the gut microbiota (GM) has recently gained increasing attention because of its emerging role as a modulator of the immune response. Several studies analyzed the diversities between immunotherapy-sensitive and immunotherapy-resistant cohorts, evidencing that particular GM profiles were closely associated to treatment effect. In addition, other data documented that interventional GM modulation could effectively enhance efficacy and relieve resistance during immunotherapy treatment. Diet represents one of the major GM determinants, and ongoing studies are examining the role of the food-gut axis in immunotherapy treatment. Here, we review recent studies that described how variations of the GM affects patient’s responsivity to anti-cancer immunotherapy and how diet-related factors impact on the GM modulation in cancer, outlining potential future clinical directions of these recent findings.

    Key words: Immune response; Immunotherapy; Programmed cell death protein 1; PD-L1; Cancer; Gut microbiota; High fiber diet

    INTRODUCTION

    The role of the immune system in tumor control has been a topic of discussion for many years but the current opinion is that cancer is a genetic-based disease that arise when somatic cells acquire multiple mutations overcoming the barriers that normally keep them under control (see the cancer immunoediting, well reviewed by Schreibeet al[1]). The host immune system plays many roles in cancer prevention such as: (1) Suppression virus-induced tumors contrasting the viral infections; (2) Prevention of the setting of an inflammatory environment pro-tumorigenesis; and (3) Elimination of tumor cells that express ligands for receptors active on innate immune cells and tumor antigens recognized by the adaptive immune cells[2]. On the other side, cancer cells, thanks to their genetic instability, can escape from immunosurveillance and potentially lead to cancer. Therefore, a targeted immunotherapy acts as an innovative anti-cancer approach, able to boost the host anti-tumor immune response, and, concomitantly, help to “hit” recurrence mechanisms and cancer resistance[3].

    Recent clinical and preclinical (in vitroand animal models) studies have revealed that the gut microbiota (GM) is implicated in modulating the efficacy and toxicity of anti-cancer treatment, like chemotherapy and immunotherapy[4]. The GM is a conglomerate of microorganisms composed of trillions of microbes, including viruses, bacteria, fungi and protozoa, with the greater population harbouring in the intestine. It is composed of two predominant phyla, namedFirmicutesandBacteroidetes(approximately 90% of the total bacteria), while the remaining 10% are partitioned betweenVerrucomicrobia,ProteobacteriaandActinobacteria[5]. GM plays an important role in host nutrition, metabolism and physiology, as well as the protection against pathogens and the development of the immune system. Notably, if on the one hand the microbiota participates in the maturation of the host's immunity, on the other hand its distribution is in turn modulated by the host's immune system[6]. In addition, the microbiota helps in aliment digestion from otherwise indigestible molecules and generates essential vitamins (K and B)[7]. Moreover, the intestinal dysbiosis (defined as a disequilibrium of the microbiota composition) has been found to be linked to the tumor initiation and progression[8]. Recent studies documented that anomalous microbiota-host interactions are associated with various neoplasia like gastric, colorectal and liver cancer[9,10]. Furthermore, a dysbiotic gut microbiota can also impact the tumor therapeutic outcome, with the latter deeply associated with the GM capacity to metabolize anti-tumoral molecules, as well as to regulate inflammation pathways and host's immune response[9]. In particular, the GM is able to influence anti-tumor immune responses through innate and adaptive immunity and the therapeutic response may be enhanced through its modulation[11,12].

    Nowadays, it is of utmost importance to improve the therapeutic outcome of patients, developing novel approaches to modulate the GM by strategies without any associated risk, as dietary intervention[13]. In general, diet has a direct role in cancer prevention, prognosis and therapies, deeply supported by animal model, epidemiological and clinical studies. Concerning nutritional patterns, diets rich in plant-based foods such as vegetables, fruit, legumes and whole grains are known to have beneficial effects due to the significant amount of fiber and antioxidant compounds, which exert an inhibitory effect on several carcinogenic pathways, including the carcinogens’ activation, cell cycle regulation, cell signaling, angiogenesis and inflammation[14]. On the contrary, a high intake of refined cereals, sugar-sweetened beverages, alcohol, red and processed meat seems to have detrimental effects, deriving from the large amount of simple sugars, salt, ethanol metabolites, saturated and trans fatty acids, which are related to pro-inflammatory effects, and alterations to cell proliferation and apoptosis[15,16]. Thus, healthy dietary habits are not only useful for weight control, but indirectly influences cancer risk since there are increasing evidence on the link between obesity and carcinogenesis. The obesity is associated with inflammation, endocrine and metabolic alterations, which increase cell proliferation and exert anti-apoptotic effects (in other words, the tumor cells do not self-destruct even after serious DNA damage)[17]. While nutritional problems such as obesity can induce carcinogenesis, cancer therapies can promote both malnutrition and weight loss. In cancer patients, weight loss can be caused by several factors, such as low energy intake, deficiency in nutrient absorption, tumor-induced catabolism and treatment side effects, resulting in therapeutic failure and poor quality of life[18]. Therefore, it seems clear that proper nutrition in cancer patients is crucial not only to prevent the malnutrition risk, but also to improve the therapy effectiveness. Indeed, recent studies suggest that diet plays a crucial role also in the treatment of cancer patients, due to the chemo-protective effects of some foods - such as omega-3 fatty acids or polyphenolic compounds - and the synergistic effect in suppressing cell proliferation[19]. On the other hand, some foods can also generate toxicity or interact with a particular type of treatment such as oral chemotherapy[16]. Therefore, it appears strategical to implement both personalized pharmacological and non-pharmacological interventions taking into account not only the histopathological cancer characteristics but also the environmental factors and the nutritional requirements of patients. Interestingly, as previously reported, diet components could act on cancer treatment also indirectly by changing the GM composition[13]. Based on the “food-gut” axis, this review aims to discuss the emerging link between immunity, diet and GM with a special focus on immunotherapy (using the immune checkpoint inhibitors - ICIs), along with recent observations that could connect dietary-related modulation of microbiota with anti-cancer therapies outcome.

    “MICROBIOME-IMMUNITY AXIS” IN CANCER IMMUNOTHERAPY AND NEW INSIGHTS ON THE IMPACT OF DIETARY FACTORS

    Regarding the GM impact on the host immune system, the current years witnessed the publication of marking breakthrough, profoundly correlating the patients' microbiota profile with the positive outcome of cancer immunotherapy using the ICIs[20], Chimeric antigen receptor T cells (CAR-T) and vaccines[21]. ICIs are one of the main current therapeutic anti-cancer strategies[22]. Cancer cells presented on their surface immune checkpoint molecules that interact with CD8+T cells, leading to tumor escape from immune system cells[23]. ICIs inhibit the interactions between molecules of the immune checkpoint and inhibitory T cellular receptors. Currently, the most adopted ICIs are monoclonal antibodies acting towards the programmed cell death protein 1 (PD-1) and its PD-L1 Ligand[24]. The food and drug administration (FDA) has approved several proteins programmed for PD-1 and PD-L1 in the treatment of solid and haematological malignancies.

    As far as it is concerned CAR-T, CAR technology was first reported in 1993 when Zelig Eshhar and coll. transduced T cells with chimeric genes encoding single-chain antibodies linked to a transmembrane region and an intracellular domain encoding the signalling adaptor for the T cell receptor[25]. CAR-T cells, currently approved in haematological malignancies, are autologous T-cell re-directed towards tumor-specific antigen. CAR-T cells contain signalling domains involved in T-cell activation as CD3ζ, CD28, 4-1BB, ICOS, and OX40. A second generation CAR connects an antigen-binding domain to the T-cell signalling domain coupled to the intracellular signalling domain of a costimulatory moleculee.g., CD28. CAR-T cell constructs may contain multiple signalling domains, that favour activation and durability of CAR-T cells, permitting therefore the implementation of the effector functions of a CAR T-cells MHCindependent[26-28]. In August 2017, the FDA approved CAR T-cells directed against CD19 for the treatment of acute lymphoblastic leukemia (ALL) and then axicabtagene ciloleucel to treat R/R large B-cell lymphoma in October 2017[26,27,29-31].

    In spite of promising clinical outcomes obtain with immune checkpoint blockade and CAR therapies, the results of therapeutic vaccination against established tumours proved to be only in part positive, with clinical benefit for cancer's patients. However, as well elucidate from Melief and colleagues, the suboptimal vaccine design and the presence of an immunosuppressive tumor microenvironment are the reasons for the shortage of cancer eradication[32].

    However, not all patients with cancer may undergo immunotherapy as some of them are resistant to therapy[33]. In the last years there has been a growing interest in identifying the immune properties of the cancer microenvironment including the characterization of tumor infiltrating lymphocytes (TILs) that seems to play an important role in response to checkpoint inhibition[34].

    Recent evidence of the interaction between specific microbes and ICIs are documented in mouse models studies[35-37], suggesting that efficacy of checkpoint blockade through PD-1 and CTLA-4 pathways could be improved through microbiota modulation (Figure 1).

    As early as 2015, Sivan and coll. observed melanoma growth in mice with distinct microbiota profiles and noticed differences in anti-tumor immune-mediated response, especially tumor-specific T cell responses and intra-tumoral CD8+ T cell accumulation. Interestingly this different response was reset upon cohousing or after fecal microbiota transplantation (FMT)[35]. In same time, a study analysed various data from patients with different neoplasia, including the antibiotic therapy when starting a CTLA-4 treatment[36]. The result showed that bacteria belonging to the generaBacteroidesandBurkholderiawere associated to the anti-tumor action of the microbiota. In response to these bacteria genera, innate immune cells release IL-12 that may activate the adaptive immune response, thus stimulating T cells. In order to endorse these data, microbes were transferred directly in germ-free mice or indirectly, by giving them feces enriched inBacteroidesof Ipilimumab-treated patients. In all cases, the response to the checkpoint inhibitors was improved[36].

    Similarly, in a different study, the GM analysis of patients who positively responded to PD-1 blockade showed an enrichment inCollinsella aerofaciens, Enterococcus faecium and Bifidobacterium longum. When responders’ fecal samples were transferred to germ-free mice, a slower tumor growth and improved therapeutic effects were observed, compared to mice receiving non-responders’ fecal samples. In addition, an increase in CD8+T cells and a decrease in Tregs (Regulatory T cells) in the tumor microenvironment was observed[38].

    These preliminary mouse studies endorsed the critical GM role in tumor ICIs therapy and encouraged clinical pursuits to determine the influence of the microbiota on human ICIs-based therapies.

    Routy and coll. demonstrated that primary resistance to ICIs can be associated to anomalous GM profiles showing that anti-PD-1/PD-L1 treatment was more efficient in patients with advanced epithelial tumor that did not receive antibiotics, compared with the outcome of those receiving antibiotics[20]. This result underlines that antibiotic treatment is able to destroy the gut microbiota, impairing immune checkpoint blockade response. In particular, whole metagenomic sequencing analyses in fecal samples, collected at diagnosis, revealed that patients responding to PD-1 blockade had different GM composition, rich inAkkermansiaandAlistipes. In addition, before the anti-PD-1 therapy, germ-free mice were treated with FMT using fecal samples from responding patients and immune response was found to be enhanced, while immune response of germ-free mice treated with FMT from non-responders was restored by oral supplementation ofAkkermansia muciniphila. These bacteria induced the efficacy of PD-1 blockade in an IL-12-dependent way by augmenting the enrollment of CXCR3+CCR9+CD4+T cells into mouse tumor beds[20].

    Gopalakrishnan and coll. analysed oral and gut microbiota of a cohort of 112 metastatic melanoma patients under anti-PD-1 therapy. The analysis of systemic immune responses revealed that patients whose gut samples where enriched in

    Clostridiales,Ruminococcaceae, orFaecalibacteriumhad more effector T cells (CD4+and CD8+) in the peripheral blood and a protected cytokine response to anti-PD-1 treatment, while patients with abundance ofBacteroidaleshad higher frequencies of Tregs, with a diminished cytokine response[39]. Immune profiling indicated an enhanced anti-tumor and systemic immunity in responding melanoma patients with a beneficial intestinal bacterial flora, as well as in germ-free mice receiving FMT from responding patients.

    A recent study analyzed patients with non–small cell lung cancer undergoing Nivolumab therapy. The higher diversity of fecal microbiota before and after anti-PD-1 therapy was related with prolonged “progression-free survival time” compared with the lower GM diversity[40]. Furthermore, patients responding to Nivolumab therapy showed higher diversity of enteric microbiota at baseline, which sustained stable composition during therapy[40].

    Finally, a study of Tanoue and coll. has identified 11 healthy human associated bacterial strains that induce IFN-γ CD8+T cells and are effective at inhibiting growth of colorectal cancer if used with ICIs[41].

    Figure 1 Gut microbiota impact on the efficacy of programmed cell death protein 1 blockade. Specific gut microbiota profiles correlates with response to programmed cell death protein 1 (PD-1) blockade in tumor patients. Fecal microbioma transplantion (FMT) from responders into mice, improve responses to anti-PD-1 treatment and correlated with increased anti-cancer CD8+ cells in the tumour environment. Mice receiving FMT from non-responders’ patients did not respond to anti-PD-1 therapy, and tumour microenvironment is enriched of immune suppressive CD4+ regulatory T cells. PD-1: Programmed cell death protein 1; FMT: Fecal microbioma transplantion; Tregs: Regulatory T cells.

    However, enteric microbiota is also able to induce toxicity to the immune checkpoint blockade. This effect was firstly observed in animal models and then in cohorts of patients[42-44]. The microbiota taxa associated in both toxicity and response to ICIs has been identified within theFirmicutesphylum andRuminococaceaefamily[39,42,43]. On the contrary, the microbiota taxa lacking response to ICIs have been identified within theBacteroidalesorder, but a higher richness in these taxa commonly diminish the incidence of toxicity[39,42,43].

    In addition, the preliminary result of the first clinical study on the impact of the food-gut axis in the relationship between GM and response to anti-PD-1 checkpoint inhibitors reported that diet and supplements might have an effect on the patient’s responsivity to anti-cancer immunotherapy, probably due to the modulation of their intestinal microbiome[45]. The analysis of fecal samples from 113 melanoma patients under anti-PD-1/PD-L1 therapy confirmed that higher microbial diversity might be associated with a positive response to treatment. Participants provided information about their dietary habits and use of probiotic supplements but only 40% of them reported to have effectively taken the supplements. Moreover, researchers found that a high fibers’ consumption (including fruits, vegetables and whole grains) is positively linked with the presence of microorganism associated to a good anti-PD-1 treatment response in previous studies[45]. On the contrary, a diet with high consumption of sugars and processed meat was negatively linked with these species. In particular, an enrichment ofRuminococcaceaefamily was associated with better therapy response, whileBacteroidalesbacteria were associated to poorer response. Furthermore, data from a subset of 46 patients treated with anti-PD-1 immunotherapy (Pembrolizumab or Nivolumab), showed that patients who consumed a high-fibers’ diet were about five times as likely to respond to anti-PD-1 therapy compared to patients who consumed a low-fibers’ diet. Surprisingly, the consumption of probiotic supplements was linked to less gut bacteria diversity[45].

    Given these results on the potential importance of fibers in the dietary survey, the same group of researchers is also starting a controlled diet trial, comparing melanoma patients eating a healthy, high-fibers’ diet to those eating a healthy diet but without a high-fibers’ component during their immunotherapy treatment (NCT03950635).

    On the other side, the link between dietary fibers and immunity could be the shortchain fatty acids (SCFAs), which are produced by fiber-fermenting bacteria and are the primary nutrient source for gut enterocytes. A very recent work of Coutzac and coll. showed that systemic microbial SCFAs’ modulate anti-CTLA-4-induced immune responses and its antitumor efficacy[46]. In particular, they demonstrated that, in mice, butyrate stops upregulation of CD80/CD86 on DC and ICOS on T cells, and accumulation of tumor specific T cells and memory T cells lead by anti-CTLA-4. As in mice, Coutzac’s group provided evidence that high butyrate was associated with less accumulation of memory and less ICOS induction on T cells in metastatic melanoma patients treated with anti-CTLA-4. This study supplies a new vision on the relationship between the GM composition GM and the clinical response to anti-CTLA-4viamicrobiota-derived metabolites.

    A very recent communication (ASCO-SITC Clinical Immuno-Oncology Symposium, February 2020), showed that cancer patients who were eating more fibers, fruits, vegetables, and whole grains had an increased abundance of pro-response and fiberfermenting bacteria. Of note, patients who consumed a high-fibers’ diet as a habitual diet were nearly five times more likely to respond to PD-1-based immunotherapy and had significantly improved progression-free survival[47]. The researchers also studied the synergy between the GM signature and dietary fiber intake. They found that patients most likely to respond to immunotherapy are those who have both “beneficial” bacteria and a fiber-rich, plant-based diet needed to feed those bacteria. The next step is to observe whether GM modulation with a controlled feeding study can influence immune response.

    TRINITY CONNECTION: DIET, GUT MICROBIOTA AND IMMUNE RESPONSE

    To date, most of the information regarding the GM modulation of the immune system through the food –gut axis comes from studies on germ-free animal models. The data showed that nutrients play a considerable role in shaping the GM composition, while the composition and GM products influence the development of the host immune system and the inflammatory response (Figure 2). At the same time, the immune system has developed multiple strategies to maintain its symbiotic relationship with commensal microbes, making the interaction between microbiota and immunity bidirectional[48].

    The influence of dietary habits on the GM composition and functionality has been widely investigated and many studies have shown that dietary changes rapidly alter the GM[49,50]. In animal models, the consumption of a western diet rich in sugar, salt and fat and low in fibers was associated with changes in microbial composition, gene expression and metabolic pathways after only one day and led to an increase in adiposity in two weeks[51]. In humans, the transition from a plant-based to an animalbased diet has resulted in a significant increase in β-diversity nearly after 24 h, with a decrease in the faecal levels of carbohydrate fermentation metabolites and an increase in amino acid fermentation metabolites[49]. GM alterations after short-term dietary interventions, however, seem to be transient and generally do not persist for more than a few days[52,53]. Long-term diets, on the other hand, have a greater influence on the GM, and habitual diet has been shown to be associated with a distinct intestinal enterotype[54]. In particular, the African diet, high in fibers, has been associated with the enterotypePrevotella, while the Western diet, rich in animal proteins and fat, has been associated withBacteroidesenterotype[55,56]. Further studies have confirmed these findings, supporting the hypothesis that diets rich in fermentable nutrients may induce an increase in beneficial bacteria such asBifidobacteriaandEubacteria, while diets rich in animal proteins and saturated fatty acids and low in fibre, increase the abundance of potentially unhealthy bacteria such asBacteroidesandClostridia[57].

    Figure 2 Relationship between dietary factors, microbiota and immune response. SCFAs: Short-chain fatty acids; TLR4: Toll-like receptor 4; TMAO: Trimethylamine N-oxide; Tregs: Regulatory T cells.

    To date, the content, quantity and type of fibers are among the most commonly accepted determinants of the GM composition[57]. Accumulated evidence has shown that fibers’ intake is associated with increased abundance of potentially beneficial species such asAkkermansia municiphiliaandRoseburiaspp, which ferment dietary fibers and produce SCFAs (acetate, propionate and butyrate). As previously reported, SCFAs are important for maintaining epithelial barrier function and regulating mucosal and systemic immunity[58]. In addition, SCFAs modulate cytokines’ production and reduce oxidative DNA damage. While the SCFAs’ impact on intestinal epithelial cells refer to their role as an energy source, the effects on the immune system are mediated by the interaction with the G-protein coupled receptor 43 (GPR43) and by the inhibition of the production of histone deacetylase[59]. This inhibition promotes T cell differentiation towards regulatory T cells (Tregs), able to produce the antiinflammatory interleukin-10 (IL-10) and other molecules such as CTLA-4 and tumor growth factor-β (TGF-β)[60]. The role of Tregs in maintaining the immunological selftolerance and in safeguarding the immune balance at the sites of environmental exposed surfaces is therefore crucial and recent studies suggested Tregs as an attractive target for T-cell-based immunotherapies[60]. Bacteria involved in the response to these therapies resemble those eating and secreting mucin (e.g.,Akkermansia municiphilia, Bifidobacterium longumandFaecalibacterium prausnitzii), which maintain barrier integrity and improve ICIs’ efficacy. The abundance of these bacteria, as demonstrated by several studies, is influenced by dietary factors such as fibers and proteins’ intake[61].

    Moreover, the fibers can influences the immune systemviathe synthesis of glycans by the bacteria of theBacteroidetesphylum. The commensal bacteriaBacteroides fragilis, for example, produce a particular immunosuppressive glycan, the polysaccharide A, which works as a toll-like receptor 2 (TLR2) ligand and promote Tregs’ differentiation[62].Bacteroides fragilisalso induces an IL-10 response in intestinal T cells, preventing the expansion of Th (helper)17 cells and the potential damage to the mucosal barrier[63].

    In addition to fibers, other nutrients are involved in modulating the immune system, either directly, by interacting with the host through the intestinal immune system, or indirectly, by modulating the GM composition. Omega-3 fatty acids, for example, modulate the inflammation by inducing a transient increase in some SCFAsproducer bacterial genera and by interacting with the G protein-coupled receptor 120 (GPR120)[64]. GPR120 is primarily expressed by the macrophages, and binding with omega-3 fatty acids supress the production of tumor necrosis factor alpha (TNF-α) and IL-6, decreasing the macrophage-induced tissue inflammation. Similarly, saturated fatty acids, proteins and vitamins influence the host inflammatory responses through the TLR4 activation[65], the increase in trimethylamine-n-oxide (TMAO) synthesis and the expression of mucin 2[66,67], and the induction of tolerogenic dendritic cells and Tregs’ differentiation, respectively[68].

    Finally, the use of probiotics and prebiotics has also been studied in relation to the GM modulation and the immune system. Although some evidence suggest that their consumption can restore innate and adaptive immunity, human supplementation trials have produced conflicting results[69,70]. Diet supplement of microbiota may be a double-edged sword as potential risks of bacteremia, sepsis, and multi-organ failure associated with the use of probiotics have been reported, especially in immunecompromised populations or in subjects with metabolic hyper-inflammatory conditions[71]. Despite of that, probiotics’ administration in multiple trials has shown beneficial effects on ameliorating diarrhea and other gut-related damages following anti-cancer therapy, thus re-establishing a healthy GM composition[72].Lactobacilliwere administrated to cancer patients to re-populate the compromised patients’ GM, thus re-establishing the levels and functionality of the commensal bacteria, depleted after the treatments[73]. Regardless the beneficial effects, larger and controlled clinical trials are further needed to truly endorse both the efficacy and the safety of administering selected species of probiotics during or following anti-cancer treatments. Therefore, as previously suggested, a safer way to modulate the GM could be through dietary interventions or supplementation with prebiotics such as oligosaccharides, fructans, and galactans, which are known to increase the proportion of potentially beneficial bacteria (e.g.,Bifidobacteria) and the production of SCFAs.

    FUTURE STRATEGIES TO IMPROVE THE RESPONSE TO IMMUNOTHERAPY THROUGH THE FOOD-GUT AXIS

    Based on the aforementioned results, the GM profile might be studied as a predictive or prognostic biomarker for anti-cancer treatment efficacy. As previously stated, higher diversity in the intestinal microbiota was associated with a better response rates to immune checkpoint blockade[39], which suggests that assessing community richness and proportion of “detrimental” and “beneficial” bacterial, prior to immunotherapy, might be crucial for the outcome trend and treatment decision. In the next future, the GM profile could be coupled with other known parameters related to outcome such as cancer mutational burden and T cell infiltration. Moreover, GM composition could be used to indicate additional interventionsviathe microbiota to improve immunotherapy effectiveness or alternatively decrease therapy related toxicity.

    However, the role of external influencers, such as medications, probiotics, prebiotics and postbiotics’ administration and dietary pattern on the GM modulation and the potential need to monitor these items during cancer therapy, have to be thoroughly investigated.

    In order to favour the expansion of beneficial bacteria or, conversely, “starving” detrimental bacteria, adjunctive therapeutic strategies, as preparative regimens (viadietary supplementation) prior to modulation of the gut microbiota, could be considered as upcoming ways to increase the efficacy of primary cancer immunotherapy (Figure 3).

    The administration of beneficial or immune-potentiating probiotic, provided as an immunotherapy adjuvant, offers a more achievable system of microbial manipulation in the clinical setting. Probiotics are inexpensive and are generally regarded as safe. In addition, the genetic manipulation of the microbes is a strategy that alters the bacterium’s existing capacities through the insertion of new genes in order to improve beneficial properties[74]. Moreover, in preclinical experiments, some phages have been already used to reduce pathogenic microbes in the commensal community, and could be further engineered to target strains efficacy[74]. Clinical trials to evaluate the impact of probiotics’ administration on treatments with checkpoint inhibitors have been initiated[75]. Notably, a double-blind clinical trial in colorectal cancer, revealed the positive effects of the probioticLactobacillus johnsoniion the GM composition[76]. In addition, a preoperative probiotic therapy withSaccaromices bulardiiinduced downregulation of pro-inflammatory cytokines within the colonic mucosa, with lower IL-10, IL-1β, and IL-23A mRNA levels[77]. This last result proved that probiotic administration could influence the local immunity. An ongoing protocol for patients with stage I-III breast cancer is actually analysing the effects of probiotics on CD8+T cell infiltrate (NCT03358511). Furthermore, a research using the keywords “cancer”, “probiotics” and immunotherapy returned three ongoing studies from the website http://www.clinicaltrials.gov. Especially, the BISQUIT study (NTC03870307) is a phase-II randomized protocol of the use of pre-and probiotics during the definitive treatment of chemotherapy-radiotherapy for patients with localized anal canal squamous cell cancer (ACSCC). The aim is to increase the effectiveness of conventional treatment. ACSCC is, in many cases, a virus-associated tumor and therefore potentially immunogenic; immunotherapy is a promising strategy in ACSCC, so pre- and probiotics stimulating the immune system through the GM modulation, might improve oncological outcomes.

    Concerning prebiotics, in theory, if they are administered to the immunotherapy and consequently lead to the growth of beneficial microbes, they could have a helpful impact on rebalancing the intestinal microbiota inducing the host to react favourably to immunotherapies. The dietary supplementation with plant polysaccharide inulin as prebiotic has already revealed an increase ofBifidobacteriumandFaecalibacteriumspecies, previously associated with immunotherapy positive response[78]. Dietary fibers have also shown to induce a decrease in the abundance of immune-promotingF. prausnitzii[79].

    Figure 3 Potential strategies to shaping the gut microbiota through the “food- gut axis” and enhance immune checkpoint inhibitors’ response. In order to obtain a favourable microbiota modulation, adjunctive therapeutic strategies, as preparative regimens (via prebiotics, prebiotics, postbiotics or dietary supplementation) could be considered as upcoming ways for improving the efficacy of immunotherapy response. PD-1: Programmed cell death protein 1.

    Dietary interventions, having a low cost and safe profile, represent a straightforward opportunity for studying the association of microbiota and downstream immune manipulation in tumor. As previously reported, the literature in this field has suggested the responsiveness of particular taxa and their induced metabolites to several immune parameters and nutrients and provides exploratory insight into how dietary modulation could impact the intestinal microbiome and immune health[80,81], with parallels that can be drawn in the immunotherapy. Interestingly, a very recent study revealed that dietary deprivation of non-essential aminoacids improved anti-PD-1 immunotherapy in a mouse model of colon cancer[82].

    Finally, studies show that some nutrition formulation called “immunonutrients” containing essential aminoacids, omega-3 fatty acids, SCFAs and nucleotides could induce particular effects on immune system. Nowadays, these new developed formulas have improved outcome in tumor patients receiving chemo-radiotherapy, decreasing acute toxicity and modulating the immune and inflammatory response.

    Immunonutrition, defined as a modulation of the immune system provided by specific interventions that modify dietary nutrients, is an emerging field in oncology, and further research is needed, especially focusing on its effects in cancer immunotherapy[83,84]. The combination of immunotherapies with the support of immunonutrition may provide future therapeutic approaches.

    CONCLUSION

    In the past decade, immunotherapy propelled the advancement of oncology therapeutics. However, only in the very recent few years we have gained significant insights into the role of GM in cancer immunotherapy response, giving new alternative explanations on patients’ resistance acquisition.

    There is also evidence that the food-gut axis is involved in the modulation of gut microbiota, resulting in synergistic effects during cancer immunotherapy. The first clinical trials on dietary modulation of the microbiota involving cancer patients undergoing immunotherapy are now ongoing, giving further opportunities to improve efficacy and relieve resistance.

    Further investigations should determine the bacterial combination pools needed to help the anti-cancer response and how to develop such combinations and, in addition, the optimal dietary strategies to enhance the immunotherapy strategies, modulating the intestinal microbiota.

    ACKNOWLEDGEMENTS

    The authors thank Dr. Elisangela Miceli, PhD for her English language revision.

    黄色日韩在线| 午夜精品在线福利| aaaaa片日本免费| 人妻久久中文字幕网| 啦啦啦韩国在线观看视频| 日韩精品中文字幕看吧| 伊人久久大香线蕉亚洲五| 九九久久精品国产亚洲av麻豆 | 禁无遮挡网站| 欧美极品一区二区三区四区| 国产伦在线观看视频一区| 日本黄色视频三级网站网址| 男女做爰动态图高潮gif福利片| 国产成人福利小说| 日本 欧美在线| 免费在线观看成人毛片| 国产av麻豆久久久久久久| 亚洲欧美精品综合一区二区三区| 亚洲精品一区av在线观看| 欧美黄色片欧美黄色片| 成人午夜高清在线视频| 国产单亲对白刺激| 亚洲无线观看免费| 波多野结衣高清无吗| 久久精品夜夜夜夜夜久久蜜豆| 欧美日韩中文字幕国产精品一区二区三区| 久久久色成人| 亚洲在线自拍视频| 国产亚洲精品久久久久久毛片| 人人妻人人澡欧美一区二区| 国产黄a三级三级三级人| 欧美黑人巨大hd| 午夜激情福利司机影院| 天堂av国产一区二区熟女人妻| 在线a可以看的网站| 久久国产乱子伦精品免费另类| 五月玫瑰六月丁香| 禁无遮挡网站| 夜夜躁狠狠躁天天躁| 在线十欧美十亚洲十日本专区| ponron亚洲| 精品国产美女av久久久久小说| 少妇裸体淫交视频免费看高清| 久久久国产成人免费| 国产av一区在线观看免费| 欧美乱色亚洲激情| 亚洲美女黄片视频| 精品国产乱码久久久久久男人| 麻豆国产av国片精品| 久久久久精品国产欧美久久久| 久久精品亚洲精品国产色婷小说| 2021天堂中文幕一二区在线观| 亚洲av成人av| 99精品久久久久人妻精品| 国产精品一区二区免费欧美| 人妻夜夜爽99麻豆av| 久久天堂一区二区三区四区| 禁无遮挡网站| 亚洲 欧美一区二区三区| 亚洲 欧美 日韩 在线 免费| www.999成人在线观看| 一边摸一边抽搐一进一小说| 制服人妻中文乱码| 老汉色∧v一级毛片| 国产精品一及| 一本一本综合久久| 丁香六月欧美| 亚洲精品在线观看二区| 久久精品综合一区二区三区| 舔av片在线| 亚洲精品中文字幕一二三四区| 精品国产亚洲在线| 一进一出好大好爽视频| 毛片女人毛片| 日日摸夜夜添夜夜添小说| 我的老师免费观看完整版| 99热只有精品国产| 一级作爱视频免费观看| 免费观看精品视频网站| 男人舔奶头视频| 亚洲av成人av| 97超级碰碰碰精品色视频在线观看| 欧美另类亚洲清纯唯美| 亚洲人与动物交配视频| 岛国在线免费视频观看| 久久九九热精品免费| 在线观看午夜福利视频| 国产成人aa在线观看| 日韩有码中文字幕| av女优亚洲男人天堂 | 伦理电影免费视频| 高清在线国产一区| 一级作爱视频免费观看| 操出白浆在线播放| 三级毛片av免费| 免费在线观看亚洲国产| 精品熟女少妇八av免费久了| 操出白浆在线播放| 亚洲精品456在线播放app | 亚洲一区二区三区不卡视频| 免费无遮挡裸体视频| 亚洲电影在线观看av| 婷婷亚洲欧美| 欧美极品一区二区三区四区| 精品久久久久久久久久久久久| 真人做人爱边吃奶动态| 亚洲一区二区三区不卡视频| 一个人看的www免费观看视频| 欧美三级亚洲精品| 亚洲乱码一区二区免费版| 久久久成人免费电影| 五月玫瑰六月丁香| 变态另类丝袜制服| 男女床上黄色一级片免费看| 国产91精品成人一区二区三区| 中文字幕熟女人妻在线| 亚洲欧美一区二区三区黑人| 麻豆av在线久日| 亚洲人成电影免费在线| 99久久综合精品五月天人人| 久久热在线av| 欧美乱色亚洲激情| av天堂中文字幕网| 午夜视频精品福利| 久久人人精品亚洲av| 国产免费av片在线观看野外av| 床上黄色一级片| 亚洲性夜色夜夜综合| 久久久久久久精品吃奶| 男插女下体视频免费在线播放| 国产精华一区二区三区| 亚洲欧美激情综合另类| 美女扒开内裤让男人捅视频| 日日夜夜操网爽| 免费在线观看视频国产中文字幕亚洲| av天堂中文字幕网| 波多野结衣高清无吗| 热99在线观看视频| 久久中文字幕人妻熟女| 亚洲欧美日韩高清专用| 国产成人一区二区三区免费视频网站| 婷婷丁香在线五月| 欧美在线一区亚洲| 成人特级av手机在线观看| 亚洲自拍偷在线| 十八禁网站免费在线| 中国美女看黄片| 欧美丝袜亚洲另类 | 黄色丝袜av网址大全| 欧美成人免费av一区二区三区| 亚洲在线自拍视频| 久久国产精品影院| 国产成人系列免费观看| 亚洲真实伦在线观看| 亚洲片人在线观看| 亚洲精品美女久久久久99蜜臀| 哪里可以看免费的av片| 九九久久精品国产亚洲av麻豆 | 色噜噜av男人的天堂激情| 91av网一区二区| 一区福利在线观看| 18禁国产床啪视频网站| 国产黄a三级三级三级人| 一个人免费在线观看电影 | 成年女人看的毛片在线观看| 亚洲专区中文字幕在线| 在线视频色国产色| 男人舔女人下体高潮全视频| 天堂动漫精品| 99热6这里只有精品| 国产精品99久久久久久久久| 在线免费观看的www视频| 成人性生交大片免费视频hd| 国内精品一区二区在线观看| 床上黄色一级片| 亚洲一区高清亚洲精品| 熟女电影av网| 久久中文字幕人妻熟女| 亚洲在线自拍视频| 国产一区二区在线观看日韩 | 国产麻豆成人av免费视频| 国产免费男女视频| 男女床上黄色一级片免费看| 人妻久久中文字幕网| 日本黄色视频三级网站网址| 51午夜福利影视在线观看| 成人18禁在线播放| 99国产极品粉嫩在线观看| 成人午夜高清在线视频| 成人精品一区二区免费| 在线永久观看黄色视频| 欧美黄色淫秽网站| 999久久久精品免费观看国产| 成在线人永久免费视频| 精品一区二区三区av网在线观看| 美女大奶头视频| 十八禁人妻一区二区| 国产激情偷乱视频一区二区| 欧美午夜高清在线| 日本黄色片子视频| 两个人的视频大全免费| 亚洲五月天丁香| 99热精品在线国产| 国产又色又爽无遮挡免费看| 久99久视频精品免费| 日本熟妇午夜| 日韩三级视频一区二区三区| 日韩欧美在线二视频| 亚洲中文字幕一区二区三区有码在线看 | or卡值多少钱| 亚洲天堂国产精品一区在线| 一级a爱片免费观看的视频| 18禁裸乳无遮挡免费网站照片| 小蜜桃在线观看免费完整版高清| 美女黄网站色视频| 久久久久国产一级毛片高清牌| 日韩中文字幕欧美一区二区| 少妇裸体淫交视频免费看高清| 最新美女视频免费是黄的| 久久精品人妻少妇| 丝袜人妻中文字幕| 超碰成人久久| 亚洲中文av在线| 精品午夜福利视频在线观看一区| 97碰自拍视频| 久久午夜亚洲精品久久| 成人国产综合亚洲| or卡值多少钱| 免费在线观看日本一区| 亚洲激情在线av| 热99re8久久精品国产| 亚洲av五月六月丁香网| 黄色视频,在线免费观看| 日韩欧美国产在线观看| 国产精品香港三级国产av潘金莲| 欧美丝袜亚洲另类 | 熟女人妻精品中文字幕| 国产亚洲av高清不卡| 亚洲av电影在线进入| 丰满人妻熟妇乱又伦精品不卡| 男人舔女人的私密视频| 真人一进一出gif抽搐免费| 99国产精品一区二区三区| 亚洲熟妇熟女久久| 亚洲天堂国产精品一区在线| 一区福利在线观看| 国产97色在线日韩免费| 国产三级中文精品| 精品一区二区三区视频在线 | 少妇丰满av| 狂野欧美白嫩少妇大欣赏| h日本视频在线播放| 嫩草影院精品99| 最新美女视频免费是黄的| 搡老岳熟女国产| 日韩有码中文字幕| 欧美日韩综合久久久久久 | 一级毛片高清免费大全| 美女高潮喷水抽搐中文字幕| 欧洲精品卡2卡3卡4卡5卡区| av天堂在线播放| 久久午夜亚洲精品久久| 亚洲熟女毛片儿| 我要搜黄色片| 窝窝影院91人妻| 久久久成人免费电影| 免费在线观看成人毛片| 国产精品av久久久久免费| 特大巨黑吊av在线直播| 亚洲专区中文字幕在线| 麻豆成人午夜福利视频| 特级一级黄色大片| 黄片小视频在线播放| 亚洲第一欧美日韩一区二区三区| 99国产极品粉嫩在线观看| 免费观看的影片在线观看| 激情在线观看视频在线高清| 亚洲狠狠婷婷综合久久图片| 美女被艹到高潮喷水动态| 久久天堂一区二区三区四区| 久久草成人影院| 亚洲av成人不卡在线观看播放网| 亚洲精华国产精华精| 久久久久免费精品人妻一区二区| 国产欧美日韩精品亚洲av| 色尼玛亚洲综合影院| 2021天堂中文幕一二区在线观| 99在线视频只有这里精品首页| 在线观看66精品国产| 免费大片18禁| 99久久99久久久精品蜜桃| 精品国产美女av久久久久小说| 性欧美人与动物交配| 国产爱豆传媒在线观看| av视频在线观看入口| 国产高清videossex| 欧美av亚洲av综合av国产av| 免费搜索国产男女视频| 一区二区三区国产精品乱码| 99在线人妻在线中文字幕| 国产aⅴ精品一区二区三区波| 搡老岳熟女国产| 99久久精品国产亚洲精品| 欧美一区二区精品小视频在线| 18美女黄网站色大片免费观看| 天天一区二区日本电影三级| 一夜夜www| 成人精品一区二区免费| 视频区欧美日本亚洲| 人妻丰满熟妇av一区二区三区| 婷婷六月久久综合丁香| 亚洲欧美精品综合久久99| 女人高潮潮喷娇喘18禁视频| 在线免费观看不下载黄p国产 | 亚洲精品中文字幕一二三四区| 色综合婷婷激情| 亚洲熟妇熟女久久| 国产激情欧美一区二区| 国产av不卡久久| 男女那种视频在线观看| 88av欧美| 午夜精品一区二区三区免费看| 一进一出好大好爽视频| 午夜久久久久精精品| avwww免费| 狂野欧美激情性xxxx| www.自偷自拍.com| 国产精品美女特级片免费视频播放器 | 亚洲狠狠婷婷综合久久图片| 9191精品国产免费久久| 黄色视频,在线免费观看| 99国产精品99久久久久| 亚洲中文av在线| 国产探花在线观看一区二区| 国产精品一区二区三区四区久久| 男女那种视频在线观看| 中文字幕人妻丝袜一区二区| 精品国产乱子伦一区二区三区| 久久99热这里只有精品18| 99久国产av精品| 日韩欧美精品v在线| 亚洲成a人片在线一区二区| 男人舔奶头视频| 午夜精品久久久久久毛片777| 久久香蕉精品热| 欧美黑人巨大hd| 亚洲午夜精品一区,二区,三区| 日本a在线网址| 欧美日本视频| 中文字幕熟女人妻在线| 国产亚洲精品一区二区www| 视频区欧美日本亚洲| 国产欧美日韩精品一区二区| 19禁男女啪啪无遮挡网站| 久久久久久久久免费视频了| 亚洲av成人av| 看片在线看免费视频| 亚洲av成人av| 国产1区2区3区精品| 国产一区二区在线av高清观看| 99热精品在线国产| 亚洲中文av在线| 国产伦精品一区二区三区四那| 美女高潮的动态| 不卡一级毛片| 在线观看免费午夜福利视频| 97碰自拍视频| 美女高潮的动态| 色在线成人网| 精品日产1卡2卡| 国产一区在线观看成人免费| 精品午夜福利视频在线观看一区| 男女下面进入的视频免费午夜| 色av中文字幕| 18禁黄网站禁片免费观看直播| 美女高潮的动态| 久久久国产欧美日韩av| 国产精品亚洲av一区麻豆| 日韩成人在线观看一区二区三区| 91麻豆av在线| 午夜福利高清视频| 男女视频在线观看网站免费| 午夜日韩欧美国产| h日本视频在线播放| 久久久久久九九精品二区国产| 亚洲欧美日韩卡通动漫| 国产1区2区3区精品| 草草在线视频免费看| tocl精华| 欧美激情久久久久久爽电影| 国产三级黄色录像| 国产精品 欧美亚洲| 99国产极品粉嫩在线观看| 亚洲色图 男人天堂 中文字幕| 欧美精品啪啪一区二区三区| 岛国视频午夜一区免费看| 欧美色欧美亚洲另类二区| 日本黄色视频三级网站网址| 一夜夜www| 午夜精品一区二区三区免费看| 91字幕亚洲| 18禁裸乳无遮挡免费网站照片| 国产精品99久久久久久久久| 琪琪午夜伦伦电影理论片6080| 成人18禁在线播放| 日韩精品青青久久久久久| 久久久精品欧美日韩精品| 国产又黄又爽又无遮挡在线| 欧美在线黄色| 国产成人aa在线观看| 欧美日韩精品网址| 国产三级黄色录像| 国产久久久一区二区三区| 午夜福利高清视频| 久久精品91无色码中文字幕| 久久久久久久久中文| 亚洲激情在线av| 中文字幕精品亚洲无线码一区| 全区人妻精品视频| 亚洲性夜色夜夜综合| 精品久久久久久久久久免费视频| 色在线成人网| 真人一进一出gif抽搐免费| 麻豆成人av在线观看| 少妇裸体淫交视频免费看高清| 久久人妻av系列| 日韩精品青青久久久久久| 毛片女人毛片| 欧美激情久久久久久爽电影| 欧美性猛交黑人性爽| 日本三级黄在线观看| 男人舔女人的私密视频| 久久九九热精品免费| 白带黄色成豆腐渣| 国产三级黄色录像| 少妇的丰满在线观看| www日本在线高清视频| 99热只有精品国产| 亚洲av电影不卡..在线观看| 伊人久久大香线蕉亚洲五| 午夜福利在线观看吧| 韩国av一区二区三区四区| 久久精品影院6| 级片在线观看| 少妇丰满av| 亚洲精品456在线播放app | 亚洲国产高清在线一区二区三| 两个人视频免费观看高清| 久久久久久久久中文| 长腿黑丝高跟| 99久久成人亚洲精品观看| 97人妻精品一区二区三区麻豆| 一进一出抽搐动态| 一区二区三区高清视频在线| 两性夫妻黄色片| 亚洲熟女毛片儿| 欧美成人一区二区免费高清观看 | 久久久久九九精品影院| 亚洲专区中文字幕在线| 婷婷丁香在线五月| 97超视频在线观看视频| 小蜜桃在线观看免费完整版高清| av视频在线观看入口| 国产精品亚洲一级av第二区| 久久久国产成人免费| 亚洲精品一区av在线观看| 亚洲avbb在线观看| 一二三四社区在线视频社区8| 欧美成人性av电影在线观看| 国产精品98久久久久久宅男小说| 麻豆成人午夜福利视频| 无遮挡黄片免费观看| 亚洲精品456在线播放app | 日日夜夜操网爽| 精品国产乱码久久久久久男人| 一个人看的www免费观看视频| 国产亚洲精品久久久com| 国产精品久久久久久亚洲av鲁大| 老司机福利观看| 精品乱码久久久久久99久播| 黑人欧美特级aaaaaa片| 淫秽高清视频在线观看| 国产乱人伦免费视频| 真人一进一出gif抽搐免费| 最好的美女福利视频网| 久久久久精品国产欧美久久久| 亚洲精品粉嫩美女一区| 搞女人的毛片| 美女cb高潮喷水在线观看 | 欧洲精品卡2卡3卡4卡5卡区| 亚洲av成人av| 两性午夜刺激爽爽歪歪视频在线观看| 亚洲五月婷婷丁香| 国产野战对白在线观看| 中文在线观看免费www的网站| 日韩三级视频一区二区三区| 在线十欧美十亚洲十日本专区| 日本一二三区视频观看| 男女午夜视频在线观看| 中文字幕最新亚洲高清| 色综合站精品国产| 精品福利观看| 亚洲成人久久爱视频| 国产一区二区在线观看日韩 | 亚洲无线观看免费| 国产成人影院久久av| 久久欧美精品欧美久久欧美| 国产精品 欧美亚洲| 久久香蕉国产精品| 欧美不卡视频在线免费观看| 后天国语完整版免费观看| 精品久久久久久,| 伦理电影免费视频| 国产精品爽爽va在线观看网站| 色老头精品视频在线观看| 午夜福利视频1000在线观看| 亚洲乱码一区二区免费版| 日韩欧美国产在线观看| 成在线人永久免费视频| 小说图片视频综合网站| 久久久久性生活片| 国产91精品成人一区二区三区| 亚洲国产欧美网| 欧美xxxx黑人xx丫x性爽| 成人国产一区最新在线观看| 色尼玛亚洲综合影院| 久久久国产精品麻豆| h日本视频在线播放| 亚洲成人久久爱视频| 亚洲片人在线观看| 少妇的逼水好多| cao死你这个sao货| 男人舔女人的私密视频| 久久伊人香网站| 国产一区二区在线av高清观看| 欧美激情久久久久久爽电影| 别揉我奶头~嗯~啊~动态视频| 国产真人三级小视频在线观看| 精品国产乱子伦一区二区三区| 18禁美女被吸乳视频| av在线蜜桃| 成人三级做爰电影| 亚洲熟妇熟女久久| 白带黄色成豆腐渣| 午夜激情欧美在线| 91麻豆精品激情在线观看国产| 久久精品国产综合久久久| 高清毛片免费观看视频网站| av中文乱码字幕在线| 最近最新中文字幕大全电影3| 久久中文字幕一级| 欧美日韩黄片免| 老司机福利观看| 日韩三级视频一区二区三区| 精品福利观看| 免费在线观看亚洲国产| 美女黄网站色视频| 日韩国内少妇激情av| 99在线视频只有这里精品首页| 国产一区二区在线观看日韩 | 岛国在线观看网站| 麻豆成人午夜福利视频| 国产高清激情床上av| 真人做人爱边吃奶动态| 亚洲精品久久国产高清桃花| 人人妻人人澡欧美一区二区| 最新美女视频免费是黄的| 日本免费a在线| 我的老师免费观看完整版| 欧美极品一区二区三区四区| 国产亚洲欧美在线一区二区| 小说图片视频综合网站| 成人鲁丝片一二三区免费| 亚洲熟妇中文字幕五十中出| 手机成人av网站| 久久这里只有精品19| 美女黄网站色视频| www日本在线高清视频| 国产成人aa在线观看| 一进一出好大好爽视频| 又黄又粗又硬又大视频| 别揉我奶头~嗯~啊~动态视频| 草草在线视频免费看| 韩国av一区二区三区四区| 午夜精品在线福利| 国内揄拍国产精品人妻在线| 99久久99久久久精品蜜桃| 国产精华一区二区三区| 国产一区在线观看成人免费| 国产av麻豆久久久久久久| 中国美女看黄片| 精品久久久久久,| 一级毛片精品| 国产精品 国内视频| 日韩欧美国产一区二区入口| 黑人欧美特级aaaaaa片| 欧美在线一区亚洲| 亚洲真实伦在线观看| 精品久久久久久久久久免费视频| 中文字幕熟女人妻在线| 免费无遮挡裸体视频| 久久久国产成人免费| 久久久成人免费电影| 熟妇人妻久久中文字幕3abv| 可以在线观看的亚洲视频| 宅男免费午夜| 欧美绝顶高潮抽搐喷水| 黄色片一级片一级黄色片| 日韩欧美三级三区| 欧美不卡视频在线免费观看| 精品久久蜜臀av无| 国产精品av视频在线免费观看| 国产伦在线观看视频一区| 在线观看免费午夜福利视频| 国产精品免费一区二区三区在线|